New hope for pancreatic cancer patients struggling with weight loss
NCT ID NCT04098237
Summary
This study is testing whether adding a digestive enzyme supplement called Pancreaze to standard cancer care helps pancreatic cancer patients maintain their weight and improve their quality of life. The research focuses on patients who have lost significant weight and have trouble digesting food properly due to their cancer. Researchers will track if patients can stick with the enzyme treatment and measure changes in weight, nutrition, digestion, and daily activity over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
Conditions
Explore the condition pages connected to this study.